Navigation Links
Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic
Date:9/25/2007

PINE BROOK, N.J., Sept. 25 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, today announced it has been awarded a contract for $12 million for advanced development of Anthim(TM), the company's late-stage anthrax therapeutic. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health and the Biomedical Advanced Research and Development Authority, Department of Health and Human Services, under Contract No. HHSN272200700035C. To date, Elusys has received more than $32 million from NIAID/BARDA and the Department of Defense in support of Anthim and the company's Heteropolymer Antibody(TM) technology.

Elizabeth Posillico, Ph.D., President and Chief Executive Officer of Elusys, commented on the award, "Elusys is encouraged by the continued support from the U.S. Government and we look forward to extending our collaboration with NIAID/BARDA. We are confident that Elusys has developed a highly effective and valuable anthrax therapeutic for procurement under Project BioShield for addition to the U.S. Government's Strategic National Stockpile."

Dr. Posillico continued, "Inhalation of anthrax spores rapidly leads to death if patients are not treated immediately with specific antibiotics. Typically, victims of inhalation anthrax experience only vague symptoms until it is too late, when they are in toxemia, leaving antibiotics largely ineffective. Anthrax vaccines are also ineffective unless victims are immunized well in advance of exposure. Anthim represents a 'just in time anthrax therapeutic,' that in relevant models has demonstrated complete protection against an anthrax spore challenge with a single prophylactic dose, and has shown significant protection when administered up to two days after a lethal spore challenge,
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pelosi: Bush Veto of Stem Cell Bill Says No to the Hopes of Million of Families Across America
2. Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
5. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
6. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
7. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
8. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
9. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
10. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
11. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Cardinal Health today announced the completion of ... of generic pharmaceuticals, over-the-counter medications and related products to ... by Court Square Capital Partners. The $1.115 billion acquisition ... debt.  Headquartered in Livonia, ... of approximately $450 million in 2014. There are 450 ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... Series E warrants to purchase 21,917,808 shares of ... purchase 2,191,781 shares of its common stock.  Certain ...
(Date:7/6/2015)... 2015   Cepheid (Nasdaq: CPHD ) today ... 2015 second quarter ended June 30, 2015 on Thursday, ... The Company will host a management presentation ... 2015, to discuss the results.  To access the live ... at least 15 minutes before the scheduled start time ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... this weeks issue of Science,researchers from the National ... in Sweden report an,important discovery about a critical ... plays in replicating DNA in higher organisms,such as ... places us one step closer to understanding the ...
... that HIV patients can live,longer lives, PASADENA, Calif., July ... combination with a second newer agent,has proven to be ... to be published in its July 7th,special HIV/AIDS issue. ... 18,nations and more than 30 centers in the United ...
Cached Medicine Technology:NIEHS Researchers Identify Enzyme Critical in DNA Replication 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 3New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 2New Drugs in Multinational Study Show Promise in Fighting,Drug-Resistant HIV 3
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ICD-10 requirements ... leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in ... ICD-10. The ten tips are timely and relevant guidelines to help radiology practices ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Seedstock today announced ... keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the ... conference , held at the University of California-San Diego, will explore solutions and methodologies ...
(Date:7/6/2015)... , ... July 06, 2015 , ... In a split ... how to reduce their risk of having a fracture through the bone health screenings ... Awareness Day. , “We are participating because our residents need this information to remain ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Dr. Lawrence Green ... DC, area patients. Kybella is a non-surgical method to dissolve fat cells ... reducing moderate to severe fat deposits under the chin, commonly known as a double ...
(Date:7/6/2015)... ... ... Thanks to donations and a generous grant from the GAR Foundation, Senior ... patients and adult day center participants. , The Music & Memory program is committed ... families and volunteers. Music & Memory is a non-profit organization that helps provide patients ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
... NEW YORK June 4 California Cryobank ... opening of its first off-site collection center at ... full service fertility treatment center. The off-site collection center ... York metropolitan area. , , Known worldwide for ...
... , ... Enterprises, Inc. ((LLE®) receives renewal of Certified Business Enterprises from the District. , ... Washington, DC (Vocus) June ... and language testing services to business, government and non-profit organizations around the world, ...
... ... add new clinical rotations in obstetrics and gynecology at the Center for Haitian Studies ... ... University School of Medicine is pleased to announce it will add new clinical rotations ...
... ... to electronic health records. , ... Scottsdale, AZ (PRWEB) June 4, 2009 -- In Entrepreneur Magazine,s ... market segments, "sectors that are defining and juicing the new economy…," then they "sniffed ...
... ... Department published results from a promising yearlong study conducted with pediatric ... to keep them taking critical medication on schedule. By sending text ... patients experienced a rejection episode versus 12 patients prior to the ...
... ... ... Eltman, Eltman & Cooper , a leading credit and collections law firm since 1947, ... 80% of judgments go unpaid. By applying advanced analytics, law enforcement grade investigations and experts ...
Cached Medicine News:Health News:Leading Sperm Bank Expands Fertility Preservation Services to the Big Apple 2Health News:DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 2Health News:DC Government Renews Certified Business Enterprise Classification to Language Interpretation and Translation Firm 3Health News:Ross University School of Medicine Expands Clinical Rotations in Miami 2Health News:Entrepreneur Magazine: MxSecure Among 100 "Brilliant Companies" 2Health News:Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients 2Health News:Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients 3Health News:Eltman, Eltman & Cooper: The Nation's Leading Judgment Enforcement Firm 2Health News:Eltman, Eltman & Cooper: The Nation's Leading Judgment Enforcement Firm 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: